A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

Trial Profile

A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Ipilimumab (Primary)
  • Indications Malignant melanoma
  • Focus Adverse reactions
  • Acronyms IMAGE
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 07 Jun 2016 Interim results (n=1371) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 25 May 2016 Results of a sub-analysis (n =1004) presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
    • 03 Feb 2015 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top